U.S. Airlines Stock News

Universal Insurance Holdings (UVE) has been drawing fresh attention after recent trading, with the stock last closing at $42.69. Investors are weighing this price against the company’s recent returns and current profitability profile. See our latest analysis for Universal Insurance Holdings. Recent trading softness, reflected in the 1-day share price return of 1.20% and 7-day share price return of 1.66%, comes after a stronger run, with a 30-day share price return of 9.71% and year to date...

In early August 2026, ONE Gas, Inc. reported higher second-quarter and first-half net income despite lower sales, affirmed a US$0.68 quarterly dividend payable on August 31, 2026, and completed a US$375 million fixed-rate, callable senior notes offering due 2036 priced at 99.675% of par. Together with amended by-laws that expand the board chair’s committee role, these moves highlight ONE Gas’s focus on reinforcing governance, funding long-lived infrastructure, and sustaining its long-running...

Earnings and Guidance Put Doximity Stock in Focus Doximity (DOCS) is in focus after first quarter earnings showed sales of US$156.62 million with lower net income of US$24.32 million, alongside updated revenue guidance for the second quarter and full fiscal year. See our latest analysis for Doximity. Doximity’s share price has climbed 27.31% over the past 90 days and 13.94% over the past month, yet remains down 43.36% year to date, while the 1 year total shareholder return is down 62.81%...

Arcos Dorados Holdings Inc. recently reported past half-year results to June 30, 2026, with revenue rising to US$2,521.6 million from US$2,218.89 million a year earlier and net income increasing to US$81.15 million from US$36.52 million, lifting basic earnings per share from continuing operations to US$0.39 from US$0.17. The combination of higher sales and more than doubled net income suggests the company converted stronger demand into improved profitability during the first half. Next,...

Neurocrine Biosciences (NBIX) has put INGREZZA back in focus after publishing KINECT-PRO Phase 4 results that link once-daily treatment with sustained improvements in tardive dyskinesia symptoms and patient-reported quality of life in real-world settings. See our latest analysis for Neurocrine Biosciences. The INGREZZA data arrives after a mixed trading patch for Neurocrine Biosciences, with the share price down 9.6% over 30 days but still showing a 9.9% year to date share price return and a...

East West Bancorp stock has returned 168.2% over the past 3 years, yet the latest valuation work suggests a more measured picture, with the Excess Returns intrinsic value estimate pointing to upside while traditional earnings multiples look roughly in line with the market. Over the last 3 years, a 168.2% share price gain places East West Bancorp among the stronger performers, which raises the question of how much of that strength is already reflected in today’s price. Future returns may...

Northwest Natural Holding Company recently reported past second-quarter 2026 results showing sales of US$243.55 million and a net income of US$0.6 million, reversing a net loss a year earlier, and modestly higher six-month sales and earnings. The company also indicated that 2026 EPS is now expected to land in the upper half of its US$2.95–US$3.15 guidance range, pointing to stronger operating momentum across its regulated and growth platforms. With management now guiding 2026 EPS toward...

Applied Materials reported third-quarter 2026 results with sales of US$9.12 billion and net income of US$2.54 billion, alongside raising its fourth-quarter revenue outlook to US$10.25 billion. Beyond the headline numbers, the company continued its multi-year share repurchase program and expanded its EPIC Center research collaboration with UC Berkeley to accelerate AI-focused semiconductor innovation. We’ll now examine how this combination of record quarterly performance and expanded UC...

Bread Financial Holdings recently released its July 2026 performance update, outlining shifts in key credit metrics such as net principal loss and delinquency rates compared with a year earlier. This monthly snapshot gives investors a timely view into the health of Bread Financial’s card portfolio and how its risk profile is evolving. We’ll now examine how July’s changes in net principal loss and delinquency rates may alter Bread Financial’s existing investment narrative. Outshine the...

Lowe's Companies stock has delivered a 15.4% gain over the past five years, yet its current valuation picture is more balanced, with the Discounted Cash Flow (DCF) intrinsic value estimate indicating the shares are roughly in line with fair value while earnings-based multiples lean more supportive. Over five years, a 15.4% total return suggests Lowe's Companies has rewarded patient shareholders, although the path has included periods of weaker performance. Future expectations for cash...

Devon Energy (NYSE:DVN) has approved moving ahead with the Solitude Pipeline System joint venture with WhiteWater and other partners to move natural gas from the Permian Basin to the Katy, TX hub and Gulf Coast. The multi phase project is designed to expand gas takeaway capacity from the Permian and link Devon volumes to Gulf Coast LNG export and power generation markets. The Solitude Pipeline System is expected to integrate with Devon Energy's existing infrastructure platform and influence...

In recent months, Zoom Video Communications has reported solid quarterly results and launched its US$20-per-user-per-month ZoomMate AI work surface, even as billings growth and net revenue retention of 99% have highlighted softer customer expansion and demand. This mix of resilient performance, expanding AI-powered offerings, and signs of slowing momentum has sharpened debate over whether current valuation signals opportunity or future pressure on growth and margins. We’ll now examine how...

Galaxy Digital has just delivered a very large 3 year return, while the share price over the past year has declined and the valuation checks point to a mixed picture rather than a clear bargain or clear overvaluation. Galaxy Digital has returned roughly 7x over 3 years, which puts recent share price weakness in a very different context for anyone looking at longer holding periods. Progress in crypto infrastructure partnerships, such as the recently announced role providing trading and...

StoneCo Ltd. has reported past second-quarter 2026 results, with revenue increasing slightly to R$3,587.38 million while net income declined to R$444.59 million versus a year earlier. Over the first half of 2026, StoneCo’s revenue grew modestly but net income more than doubled to R$2.15 billion, highlighting the impact of non-recurring items and credit provisioning. We’ll now examine how StoneCo’s expanding but pressured credit portfolio could influence its existing investment narrative and...

Earlier in 2026, Vicor raised its full‑year revenue outlook to more than US$600 million and guided to nearly 10% sequential third‑quarter revenue growth, citing strong operating momentum and improving visibility into AI‑related power‑delivery demand. The company also moved ahead with plans for a second fabrication facility designed to roughly double current production capacity, underscoring management’s confidence that AI computing requirements could support significantly higher long‑term...

Hormel Foods (NYSE:HRL) has introduced a co-branded premium chili in partnership with Omaha Steaks, combining both companies' branding in a new convenience offering. The company is also rolling out a PLANTERS seasonal fall snack collection, featuring a mix of new and returning limited-time flavors. Both launches target demand for higher-quality convenient meals and seasonal snacking, aiming to deepen customer engagement with Hormel Foods' core brands. Consider exploring other consumer...

Artisan Partners Asset Management has recently paid a total dividend of US$0.80 per share, following an ex-dividend date of 17 August 2026, extending a dividend record that dates back to 2013. While the dividend offers a high yield appealing to income-focused investors, the payout ratio of 1.03 indicates the company is distributing more than its earnings, raising questions about how reliable this income stream may be over time. Next, we'll examine how concerns around an above-earnings...

Johnson & Johnson (JNJ) stock is in focus after FDA clearance of the MONARCH QUEST 3 bronchoscopy system, along with momentum in its Innovative Medicine segment despite ongoing STELARA biosimilar headwinds. See our latest analysis for Johnson & Johnson. At a share price of $262.37, Johnson & Johnson has a 90 day share price return of 14.07% and a year to date share price return of 26.53%. The 1 year total shareholder return of 52.58% points to strong recent momentum building around products...

On August 10, 2026, The Accountability Board submitted a shareholder proposal asking Darden Restaurants to adopt and disclose a policy requiring a formal board review and public summary whenever a director in an uncontested election receives support below 80%, following which Darden urged investors to vote against the measure in its September 23, 2026 annual meeting materials. This governance-focused clash arrives just after Darden reported strong fiscal Q4 2026 sales growth and analysts...

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Bristol-Myers Squibb stock has delivered a 40.6% 1 year return, while both its Discounted Cash Flow (DCF) intrinsic value estimate and market multiples currently point to the shares trading at a discount to what the business may be worth. The 40.6% gain over the past year suggests sentiment has improved, yet current valuation signals still indicate the market price may be below intrinsic value. Recent FDA accelerated approval for ZENBEXUS can support expectations for future cash flows, while...

US$166b in tariff refunds plus interest is quietly reshaping corporate cash piles, at the same time that fresh trade barriers and a wider US fiscal deficit keep markets on edge. That mix of extra liquidity and higher risk is creating potential winners among financial stocks that sit closest to new corporate cash. This article unpacks the tariff story and highlights three stocks exposed to these refunds that investors may want to keep on their radar. The sample stocks covered below are just a...

Crinetics Pharmaceuticals has delivered a very strong share price run over the past three years, yet its current valuation screens as expensive on market multiples and the broader checks only give it a mixed score. That combination leaves investors weighing a powerful recent return against signals that the stock is not clearly cheap at today’s price of US$84.75. Crinetics Pharmaceuticals has returned 428.0% over the past three years, which sets a high bar for any further gains to be...

Why Hesai Group Stock Is Back In Focus After Q2 Results Hesai Group (HSAI) drew fresh attention after reporting second quarter 2026 results, with higher sales and net income for both the quarter and first half of the year compared with 2025. See our latest analysis for Hesai Group. Hesai Group's earnings release comes after a strong 30 day share price return of 20.47%. However, the share price is still down 24.96% year to date and the 1 year total shareholder return has declined 32.12%, while...